PolyPid is an Israeli clinical-stage pharmaceutical company engaged in the development of products that encapsulate drugs to enable targeted, localized drug delivery into the human body over prolonged periods of time without affecting the chemistry of the drug. The core technology can be used for different product lines and PolyPid’s initial focus is on surgical site infections, a multi-billion dollar market.